TP53 and early-onset autosomal dominant Alzheimer disease: NK supplementation significantly delays the neurodegenerative process in animal models of Alzheimer's disease by decreasing the levels of IL‐6 and p53 while increasing B‐cell lymphoma 2 expression in brain neurons.23